Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin. (Q35827880)
Jump to navigation
Jump to search
scientific article published on 27 October 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin. |
scientific article published on 27 October 2015 |
Statements
Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin (English)
Leila Arabi
Fatemeh Mosaffa
Mahmoud Reza Jaafari
27 October 2015